KMTS SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Sep 14, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Jul 14, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Mar 17, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Dec 11, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Sep 12, 2025

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Jul 17, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results and Increases Full Year Guidance

Sep 14, 2026

8-K

Kestra Medical Technologies, Ltd. Announces Voting Results from 2026 Annual General Meeting

Sep 10, 2026

8-K

Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Results

Jul 14, 2026

8-K

Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results

Mar 17, 2026

8-K

Kestra Medical Technologies Reports Second Quarter Fiscal 2026 Financial Results

Dec 11, 2025

8-K

Kestra Medical Technologies, Ltd. Announces Public Offering of 6.9 Million Common Shares; Net Proceeds Approximately $148.4 Million; Closing December 4, 2025

Dec 4, 2025

Prospectus

TYPE

HEADLINE

FILED AT

424B4

SHARE RESALE REGISTRATION | Shares amount: 6,000,000 | Share price: $23 | Offering amount: $138,000,000

Dec 3, 2025

424B4

Form 424B4 - Prospectus [Rule 424(b)(4)]

Mar 6, 2025

Registrations

TYPE

HEADLINE

FILED AT

S-3ASR

April 2026 SHELF

Apr 1, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 17, 2026

S-1MEF

SHARE RESALE REGISTRATION | Shares amount: 575,000

Dec 2, 2025

S-1

OFFERING (Public Offering) - BofA Securities, Inc., Piper Sandler & Co., J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, and Wells Fargo Securities, LLC.

Dec 1, 2025

DRS

Form DRS - Draft Registration Statement

Oct 29, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 7, 2025

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Jul 28, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Jul 28, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Jul 22, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Jul 22, 2025

Ownerships

TYPE

HEADLINE

FILED AT

Moran Timothy P. (Reporting)

Nov 5, 2026

144

Form 144 - Report of proposed sale of securities

Nov 3, 2026

Mahboob Vaseem (Reporting)

Oct 29, 2026

Umberger Traci S (Reporting)

Oct 29, 2026

144

Form 144 - Report of proposed sale of securities

Oct 29, 2026

144

Form 144 - Report of proposed sale of securities

Oct 28, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Dec 3, 2025

CORRESP

Form CORRESP - Correspondence

Dec 1, 2025

CORRESP

Form CORRESP - Correspondence

Dec 1, 2025

EFFECT

Form EFFECT - Notice of Effectiveness

Mar 6, 2025

CORRESP

Form CORRESP - Correspondence

Mar 3, 2025

CORRESP

Form CORRESP - Correspondence

Mar 3, 2025

Kestra Medical Technologies, Ltd. KMTS · SEC Filings